@article {Bucholc2020.01.31.19015503, author = {Magda Bucholc and Paula L. McClean and Sarah Bauermeister and Stephen Todd and Xuemei Ding and Qinyong Ye and Desheng Wang and Wei Huang and Liam P. Maguire}, title = {Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: a longitudinal retrospective study}, elocation-id = {2020.01.31.19015503}, year = {2020}, doi = {10.1101/2020.01.31.19015503}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {INTRODUCTION Hearing aid usage has been linked to improvements in cognition, communication, and socialization, but the extent to which it can affect the incidence and progression of dementia is unknown. Such research is vital given the high prevalence of dementia and hearing impairment in older adults, and the fact that both conditions often coexist. In this study, we examined for the first time the effect of the use of hearing aids on the conversion from mild cognitive impairment (MCI) to dementia and progression of dementia.METHODS We used a large referral-based cohort of 2114 hearing-impaired patients obtained from the National Alzheimer{\textquoteright}s Coordinating Center. Survival analyses using multivariable Cox proportional hazards regression model and weighted Cox regression model with censored data were performed to assess the effect of hearing aid use on the risk of conversion from MCI to dementia and risk of death in hearing-impaired participants. Disease progression was assessed with CDR{\textregistered} Dementia Staging Instrument Sum of Boxes (CDRSB) scores. Three types of sensitivity analyses were performed to validate the robustness of the results.RESULTS MCI participants that used hearing aids were at significantly lower risk of developing all-cause dementia compared to those not using hearing aids (hazard ratio [HR] 0.73, 95\%CI, 0.61-0.89; false discovery rate [FDR] P=0.004). The mean annual rate of change (standard deviation) in CDRSB scores for hearing aid users with MCI was 1.3 (1.45) points and significantly lower than for individuals not wearing hearing aids with a 1.7 (1.95) point increase in CDRSB per year (P=0.02). No association between hearing aid use and risk of death was observed. Our findings were robust subject to sensitivity analyses.DISCUSSION Among hearing-impaired adults, hearing aid use was independently associated with reduced dementia risk. The causality between hearing aid use and incident dementia should be further tested.HighlightsHigh prevalence of dementia and hearing impairment in older adultsHearing aid (HA) use associated with a lower risk of incident dementiaSlower cognitive decline in users than non-users of HA with mild cognitive impairmentThe relationship between hearing impairment and dementia should be further testedCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Dr George Moore Endowment for Data Science at Ulster University (MB); European Union INTERREG VA Programme (MB, PLM, ST, LPM); Global Challenge Research Fund (MB, XD, QY, DW, WH), Alzheimer{\textquoteright}s Research UK (MB, SB); European Union Regional Development Fund (PLM); Northern Ireland Public Health Agency (PLM); Dementias Platform UK (DPUK) (SB); Nutricia (ST); Bohringer-Ingelheim (ST); Genomics Medicine Ireland (ST); Vifor Pharma (ST); and Putnam Associates (ST).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis research was conducted using the National Alzheimer{\textquoteright}s Coordinating Center database under application 1026.}, URL = {https://www.medrxiv.org/content/early/2020/11/19/2020.01.31.19015503}, eprint = {https://www.medrxiv.org/content/early/2020/11/19/2020.01.31.19015503.full.pdf}, journal = {medRxiv} }